374 related articles for article (PubMed ID: 8756909)
1. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis.
Buadu LD; Murakami J; Murayama S; Hashiguchi N; Sakai S; Masuda K; Toyoshima S; Kuroki S; Ohno S
Radiology; 1996 Sep; 200(3):639-49. PubMed ID: 8756909
[TBL] [Abstract][Full Text] [Related]
2. Laser therapy for breast cancer: MR imaging and histopathologic correlation.
Mumtaz H; Hall-Craggs MA; Wotherspoon A; Paley M; Buonaccorsi G; Amin Z; Wilkinson I; Kissin MW; Davidson TI; Taylor I; Bown SG
Radiology; 1996 Sep; 200(3):651-8. PubMed ID: 8756910
[TBL] [Abstract][Full Text] [Related]
3. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
Low RN; Sigeti JS
AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
[TBL] [Abstract][Full Text] [Related]
4. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique.
Boetes C; Barentsz JO; Mus RD; van der Sluis RF; van Erning LJ; Hendriks JH; Holland R; Ruys SH
Radiology; 1994 Dec; 193(3):777-81. PubMed ID: 7972823
[TBL] [Abstract][Full Text] [Related]
5. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results.
Jager GJ; Ruijter ET; van de Kaa CA; de la Rosette JJ; Oosterhof GO; Thornbury JR; Ruijs SH; Barentsz JO
Radiology; 1997 Jun; 203(3):645-52. PubMed ID: 9169683
[TBL] [Abstract][Full Text] [Related]
6. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T.
Whitney WS; Herfkens RJ; Jeffrey RB; McDonnell CH; Li KC; Van Dalsem WJ; Low RN; Francis IR; Dabatin JF; Glazer GM
Radiology; 1993 Dec; 189(3):863-70. PubMed ID: 8234717
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast.
Nunes LW; Schnall MD; Siegelman ES; Langlotz CP; Orel SG; Sullivan D; Muenz LA; Reynolds CA; Torosian MH
AJR Am J Roentgenol; 1997 Aug; 169(2):409-15. PubMed ID: 9242744
[TBL] [Abstract][Full Text] [Related]
8. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.
Stomper PC; Herman S; Klippenstein DL; Winston JS; Edge SB; Arredondo MA; Mazurchuk RV; Blumenson LE
Radiology; 1995 Nov; 197(2):387-95. PubMed ID: 7480682
[TBL] [Abstract][Full Text] [Related]
9. Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage.
Stomper PC; Herman S; Klippenstein DL; Winston JS; Budnick RM; Stewart CC
Cancer; 1996 May; 77(9):1844-9. PubMed ID: 8646683
[TBL] [Abstract][Full Text] [Related]
10. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast.
Müller-Schimpfle M; Ohmenhaüser K; Stoll P; Dietz K; Claussen CD
Radiology; 1997 Apr; 203(1):145-9. PubMed ID: 9122383
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional gadolinium-enhanced MR imaging of the breast: pulse sequence with fat suppression and magnetization transfer contrast. Work in progress.
Pierce WB; Harms SE; Flamig DP; Griffey RH; Evans WP; Hagans JE
Radiology; 1991 Dec; 181(3):757-63. PubMed ID: 1947093
[TBL] [Abstract][Full Text] [Related]
12. Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging.
Hawighorst H; Knapstein PG; Weikel W; Knopp MV; Schaeffer U; Brix G; Essig M; Hoffmann U; Zuna I; Schönberg S; van Kaick G
Radiology; 1996 Nov; 201(2):531-9. PubMed ID: 8888254
[TBL] [Abstract][Full Text] [Related]
13. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.
Kuhl CK; Bieling H; Gieseke J; Ebel T; Mielcarek P; Far F; Folkers P; Elevelt A; Schild HH
Radiology; 1997 Jan; 202(1):87-95. PubMed ID: 8988196
[TBL] [Abstract][Full Text] [Related]
14. Patterns of peripheral enhancement in breast masses: correlation of findings on contrast medium enhanced MRI with histologic features and tumor angiogenesis.
Buadu LD; Murakami J; Murayama S; Hashiguchi N; Sakai S; Toyoshima S; Masuda K; Kuroki S; Ohno S
J Comput Assist Tomogr; 1997; 21(3):421-30. PubMed ID: 9135652
[TBL] [Abstract][Full Text] [Related]
15. Peripheral washout sign on contrast-enhanced MR images of the breast.
Sherif H; Mahfouz AE; Oellinger H; Hadijuana J; Blohmer JU; Taupitz M; Felix R; Hamm B
Radiology; 1997 Oct; 205(1):209-13. PubMed ID: 9314987
[TBL] [Abstract][Full Text] [Related]
16. [The MRT of the breast with 2D-spin-echo and gradient-echo sequences in diagnostically problematic cases].
Allgayer B; Lukas P; Loos W; Kersting-Sommerhoff B
Rofo; 1993 May; 158(5):423-7. PubMed ID: 8490150
[TBL] [Abstract][Full Text] [Related]
17. The variability of fibroadenoma in contrast-enhanced dynamic MR mammography.
Brinck U; Fischer U; Korabiowska M; Jutrowski M; Schauer A; Grabbe E
AJR Am J Roentgenol; 1997 May; 168(5):1331-4. PubMed ID: 9129437
[No Abstract] [Full Text] [Related]
18. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
Peterson MS; Baron RL; Murakami T
Radiology; 1996 Nov; 201(2):337-45. PubMed ID: 8888220
[TBL] [Abstract][Full Text] [Related]
19. [A pharmacokinetic analysis of Gd-DTPA enhancement in MRT in breast carcinoma].
Hess T; Knopp MV; Hoffmann U; Brix G; Junkermann H; Zuna I; von Fournier D; van Kaick G
Rofo; 1994 Jun; 160(6):518-23. PubMed ID: 8011997
[TBL] [Abstract][Full Text] [Related]
20. Hilar cholangiocarcinomas: T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging.
Guthrie JA; Ward J; Robinson PJ
Radiology; 1996 Nov; 201(2):347-51. PubMed ID: 8888221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
